Slura - Just to clarify
Your post above used 8% of 32m to get $2.56m - This is incorrect
32m is ADO's share at 8% royalty of the $400m pa ELISA assays market.
18m is ADO's share at 8% royalty of the $220m pa Protein arrays
Total market size for research market is $620m pa
Ebioscience is a leader in the research market and this deal will be at worst cashflow positive but I would say after seeing this more like a $4-8m deal pa
When people understand how big this pie is they may realise where my enthusiasm comes from.
Even 5% achievement of the current market would see $50m per annum to ADO
$50m - $5m (maximum cost base) = $45m NPAT x PE 10 (Conservative) = 56 cents shareprice
I look forward to posting the first follower video as the crowd starts following this one!
Add to My Watchlist
What is My Watchlist?
